Lucid Diagnostics Inc LUCD
$0.87
▼ -3.28%
($-0.03)
🧊 52W Low
⬇️ Below Yest. Low
🗓️ Earnings Next Week
Open
$0.89
Prev Close
$0.90
Day Range
$0.86 – $0.90
52W Range
$0.90 – $1.63
Market Cap
$176.99M
Beta
1.15
EPS (TTM)
$-0.36
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-14 |
| Shares Out. | 190,770,000 |
| Website | luciddx.com/ ↗ |
| Phone | 13026587581 |
| Employees | 82 |
| Revenue | $1.3M |
| Gross Profit | -$369,000 |
| Net Income | -$13.9M |
| Free Cash Flow | -$46.4M |
| Total Assets | $34.1M |
| Total Liabilities | $30.1M |
| Equity | $4.0M |
About Lucid Diagnostics Inc
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Lucid Diagnostics Inc is a publicly traded company under the ticker symbol LUCD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)